Variables | PE with fever (n=59) | PE without fever (n=182) | Total (n=241) | P values |
Age | 52.518 (15.457) | 58.678 (16.452) | 57.170 (16.399) | 0.01 |
Gender (Female) | 27 (45.8%) | 94 (51.6%) | 121 (50.2%) | 0.52 |
Comorbidities | ||||
CHF | 1 (1.7%) | 23 (12.6%) | 24 (10.0%) | 0.02 |
Malignancy | 8 (13.6%) | 32 (17.6%) | 40 (16.6%) | 0.60 |
OAD | 13 (22.0%) | 34 (18.7%) | 47 (19.5%) | 0.70 |
History of smoking | 26 (44.1%) | 38 (20.9%) | 64 (26.6%) | <0.001 |
Vital signs | ||||
Tmax in 1 week of PE (°F) (±SD) | 101.576 (±0.911) | 98.719 (±0.801) | 99.419 (1.483) | <0.001 |
Heart rate (beats/min) (±SD) | 101.136 (±24.449) | 90.199 (±20.138) | 92.888 (21.743) | <0.001 |
MAP (mm Hg) (±SD) | 84.879 (±16.965) | 88.456 (±16.572) | 87.592 (16.703) | 0.15 |
Systolic BP (mm Hg) (±SD) | 115.932 (±24.143) | 123.720 (±19.685) | 121.813 (21.080) | 0.01 |
Oxygen saturation (%)(SD) | 95.724 (±5.742) | 96.808 (±3.900) | 96.535 (4.448) | 0.10 |
PE relevant data | ||||
Simple PE | 26 (44.1%) | 115 (63.2%) | 141 (58.5%) | 0.01 |
Massive and submassive PE | 33 (55.9%) | 67 (36.8%) | 100 (41.5%) | 0.01 |
Use of TPA | 4 (6.8%) | 2 (1.1%) | 6 (2.5%) | 0.05 |
Use of anticoagulation | 57 (96.6%) | 164 (90.1%) | 221 (91.7%) | 0.19 |
Laterality (Bilateral) | 30 (50.8%) | 76 (41.8%) | 106 (44.0%) | 0.28 |
Pulmonary infarct | 5 (8.5%) | 4 (2.2%) | 9 (3.7%) | 0.07 |
DVT | 15/45 (33.3%) | 23/132 (17.4%) | 38/177 (21.5%) | 0.03 |
RVSP n (±SD) | 42.370 (±13.920) | 39.411 (±13.586) | 40.079 (13.682) | 0.20 |
Infection data | ||||
Leucocyte count k/ul (±SD) | 10.976 (5.848) | 8.797 (5.013) | 9.330 (5.301) | 0.006 |
Positive blood culture within 1 week of PE | 1 (1.9%) | 1 (0.7%) | 2 (1.0%) | 1.000 |
Urine culture positive within 1 week of PE | 3 (6.2%) | 9 (7.3%) | 12 (7.0%) | 1.000 |
Antibiotics given within 1 week of PE | 37 (62.7%) | 49 (26.9%) | 86 (35.7%) | <0.001 |
BP, blood pressure; CHF, congestive heart failure; DVT, deep venous thrombosis; MAP, mean arterial pressure; OAD, obstructive airway disease; PE, pulmonary embolism;RVSP, right ventricular systolic pressure; TPA, tissue plasminogen activator; Tmax, maximum temperature.